Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for sodium-glucose cotransporter-2 inhibitors?

J Cardiovasc Med (Hagerstown). 2020 Apr;21(4):343. doi: 10.2459/JCM.0000000000000938.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Furosemide
  • Heart Failure* / drug therapy
  • Humans
  • Sodium Potassium Chloride Symporter Inhibitors / adverse effects
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects

Substances

  • Sodium Potassium Chloride Symporter Inhibitors
  • Sodium-Glucose Transporter 2 Inhibitors
  • Furosemide